Company data
DiaMedica Therapeutics Inc. employees and revenue per employee
DMAC · Biotechnology · $449M market cap
DiaMedica Therapeutics Inc. had 9 employees at the end of fiscal Dec 2018. Revenue for the year was $500,000, or $56K per employee.
The latest annual report we hold is more than two years old, so these numbers may be out of date.
Employees
9
Revenue
$500,000
Revenue / employee
$56K
Peer median $458K
Rank in industry
97 of 109
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Only one fiscal year on file so far, so there is no trend to draw yet.
DiaMedica Therapeutics Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| DMAC DiaMedica Therapeutics Inc. | 9 | $500,000 | $56K | — |
| CGON CG Oncology Inc. | 142 | $4.0M | $28K | Efficient growth |
| STTK Shattuck Labs, Inc. | 40 | $1.0M | $25K | Contracting |
| DNTH Dianthus Therapeutics, Inc. | 92 | $2.0M | $22K | Hiring into decline |
| ABSI Absci Corporation | 140 | $2.8M | $20K | Contracting |
| INBX Inhibrx Biosciences Inc. | 109 | $1.3M | $12K | Leaner |
| NGNE Neurogene Inc. | 107 | $925,000 | $9K | — |
| CLDX Celldex Therapeutics, Inc. | 198 | $1.5M | $8K | Hiring into decline |
| ARTV Artiva Biotherapeutics, Inc. | 89 | $251,000 | $3K | — |
Questions about DiaMedica Therapeutics Inc.
- How many employees does DiaMedica Therapeutics Inc. have?
- DiaMedica Therapeutics Inc. reported 9 employees for the fiscal year ending Dec 2018, in the annual report it filed on March 19, 2019.
- What is DiaMedica Therapeutics Inc.'s revenue per employee?
- DiaMedica Therapeutics Inc. brought in $500,000 of revenue in fiscal Dec 2018, which is $56K per employee. That ranks 97 of 109 companies we track in Biotechnology, where the median is $458K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare DMAC with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in DiaMedica Therapeutics Inc.'s annual reports (Form 10-K), latest filed March 19, 2019. This is data, not a recommendation to buy or sell DMAC.